EpidermalGrowthFactor-likeProtein7MonoclonalAntibody
EGF-L7(EpidermalGrowthFactorLikeProtein7)isamulti-domainproteincontainingtwoEGFlikedomainsandoneEMIdomain.Itisexpressedalmostexclusivelyinendothelialcellsandfunctionstopromotenormaldevelopmentofthevascularsystem.
EGF-L7iscapableofantagoNISTicbindingtoNotchreceptorsresultingintheinhibitionofNotchsignalinginHUVECandneuralstemcells.Inresearchmodelsinducinghypoxiaandsubsequentreoxygenation,(H/R),EGF-L7caninhibitICAM-1expressionandenhancetheinhibitionofNF-kappaBactivation.Additionally,EGF-L7isachemoattractantforendothelialcellsandbindstotheextracellularmatrix.TheoverexpressionofEGF-L7isobservedinvariouscancers,andisgenerallycorrelatedwithincreasedmetastasisandapoorprognosis.
ThisantibodyreactswithhumanEGFL-7protein.
ELISA:useat1-10ug/ml.Immunoblotting:useat1-5ug/ml.Abandof~30kDaisdetected.
Immunohistochemistry:Useat2-10ug/ml.
Thesearerecommendedconcentrations.Endusershoulddetermineoptimalconcentrationsfortheirapplications.
Reconstituteindistilledwater.
Thisproductisstableforatleastone(1)yearat-20oCto-70oC.Reconstitutedproductshouldbestoredinappropriatealiquotstoavoidrepeatedfreeze-thawcycles.
Forinvitroinvestigationaluseonly.Notforuseintherapeuticordiagnosticprocedures.
美国QED Bioscience 公司(www.qedbio.com)是专业的抗体公司,有20年的历史,是世界著名的抗体生产商。QED生物科技为科研客户提供优质的单克隆和多克隆抗体产品。 是一家提供全面服务的并提供额外服务的公司,能提供超过1500的单克隆和多克隆抗体的用于多领域的研究。